Request for Information – Prophylactic Platform for Medical Countermeasures
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
W6QK ACC-APG
Contract Value
Not provided
Codes & Classification
Solicitation Number
W911SR27SPPFC
NAICS
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Classification Code
AC15
Additional Details
Documents3
The Department of the Army, under the auspices of the Department of Defense, has issued a Special Notice (Procurement Identifier: W911SR27SPPFC) seeking information from qualified organizations regarding the advancement of prophylactic medical countermeasures (MCMs) for chemical, biological, radiological, and nuclear defense. This Request for Information (RFI) is managed by the Capability Program Executive for Chemical, Biological, Radiological and Nuclear Defense (CPE CBRND), specifically through the Medical - Accelerated Defense Pharmaceuticals program.
The primary objective of this procurement activity is to identify and assess existing prophylactic MCMs that are manufactured using established platform technologies. The focus is on candidates that have demonstrated clinical safety or possess robust preclinical data supporting their immunogenicity, safety, and efficacy. The intent is to accelerate the development and potential deployment of these countermeasures to enhance national defense capabilities against CBRN threats.
Key requirements for respondents include the ability to provide detailed information on existing prophylactic MCMs that align with the program’s objectives. Submissions should emphasize the maturity of the platform technology, the extent of clinical or preclinical data available, and the potential for rapid progression toward advanced development and deployment. The expected deliverables at this stage are comprehensive responses that detail the technical capabilities, supporting data, and readiness level of the proposed MCMs.
This notice is classified under NAICS Code 541715, which pertains to Research and Development in the Physical, Engineering, and Life Sciences (excluding Nanotechnology and Biotechnology), and Product Service Code AC15. The place of performance is Frederick, Maryland, USA. There are no set-aside requirements associated with this opportunity, making it open to all capable entities regardless of size or socioeconomic status.
The contracting activity is managed by W6QK ACC-APG, a federal office within the Department of the Army. Interested parties are encouraged to direct inquiries or submit responses to the designated points of contact: Scott Hoffman ([email protected]) and Alexander Mayatte ([email protected]).
This RFI is currently active, with a posting date of October 19, 2026, and a response deadline of November 18, 2026. Additional details and attachments related to this opportunity can be accessed via the official SAM.gov listing (Opportunity ID: d1042ec721db4344bba59bae0c6caa96).
Contractors with expertise in the development of medical countermeasures using established platform technologies, and with supporting clinical or preclinical data, are encouraged to review the full notice and consider submitting a response. This opportunity represents a significant initiative to bolster the nation’s preparedness and response capabilities against CBRN threats through innovative and mature prophylactic solutions.